News

Ghiasvand R (2026)
High-Risk Stage II Melanoma: AJCC Staging anomaly or understaging dilemma?
Br J Dermatol (in press)
DOI 10.1093/bjd/ljaf523, PubMed 41483011

Mattavelli D, Compagnoni M, Calza S, Ravanelli M, Plana M, Wichmann G, Paderno A, Zhan Y, Smussi D, Rondi P, Pinacoli A, Medda A, Lorini L, Khelik K, Hovig E, Maffini FA, Kalogerini M, Alberti A, Farina D, Dietz A, Mesia R, Piazza C, Chiocca S, Bossi P, PRESERVE Consortium (2025)
A multiomic framework for predicting laryngo-esophageal dysfunction following induction chemotherapy in hypopharyngeal-laryngeal carcinoma
ESMO Open, 11 (1), 105933 (in press)
DOI 10.1016/j.esmoop.2025.105933, PubMed 41468687

Kotsopoulos J, Apostol AI, Metcalfe K, Jorgji D, Cybulski C, Gronwald J, Lubinski J, Moller P, Kim RH, Aeilts A, Ramón Y Cajal T, Pal T, Bordeleau L, Karlan BY, Singer CF, Foulkes WD, Couch FJ, Zakalik D, Fruscio R, Tung N, Sun P, Monteiro AN, Narod SA, Akbari MR, Hereditary Breast Cancer Clinical Study Group (2025)
The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in BRCA1
Curr Oncol, 32 (12)
DOI 10.3390/curroncol32120705, PubMed 41440233